Drug Shortage Report for ULTRAVIST 370
| Report ID | 218759 |
| Drug Identification Number | 02078619 |
| Brand name | ULTRAVIST 370 |
| Common or Proper name | IOPROMIDE |
| Company Name | BAYER INC |
| Market Status | MARKETED |
| Active Ingredient(s) | IOPROMIDE |
| Strength(s) | 77% |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVASCULAR INTRAVASCULAR |
| Packaging size | 500 mL |
| ATC code | V08AB |
| ATC description | X-RAY CONTRAST MEDIA, IODINATED |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-02-15 |
| Actual start date | 2024-01-29 |
| Estimated end date | 2024-05-03 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-23 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
| Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-04-23 | French | Compare |
| v5 | 2024-04-23 | English | Compare |
| v4 | 2024-04-02 | French | Compare |
| v3 | 2024-04-02 | English | Compare |
| v2 | 2024-02-07 | French | Compare |
| v1 | 2024-02-07 | English | Compare |
Showing 1 to 6 of 6